With the support of DBT-BIRAC, ILS Bhubaneswar has established an ABSL-3 animal challenge platform for SARS-CoV2 related studies. The facility will provide service for antiviral and vaccine candidate evaluation against SARS-CoV2 infection in Syrian hamster and/or K18-ACE2 transgenic mice. The service will be provided on a fee-for-service mode. Our models are standardised with two well characterised local isolates of SARS-CoV2 and reproduce lung pathology resembling that of COVID-19 human patients.